Mesenchymal stem cells for cardiac cell therapy

Human Gene Therapy

Volumn 22, Issue 1, 2011, Pages 3-17

  Choi, Yeong Hoon ^a   Kurtz, Andreas ^b,c   Stamm, Christof ^b,d  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD79A ANTIGEN; ENDOGLIN; HLA DR1 ANTIGEN; THY 1 ANTIGEN;

ADIPOGENESIS; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CELL REGENERATION; CELL RENEWAL; CELL TYPE; CHONDROGENESIS; CLINICAL TRIAL (TOPIC); CONNECTIVE TISSUE; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FATALITY; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; LIFESPAN; MESENCHYMAL STEM CELL TRANSPLANTATION;

BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; ENDOTHELIAL CELLS; HEART; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROMAL CELLS;

MAMMALIA;

EID: 79951880790     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.211     Document Type: Article

References (167)

1. Abarbanell, A.M., Coffey, A.C., Fehrenbacher, J.W., Beckman, D.J., Herrmann, J.L., Weil, B., and Meldrum, D.R. (2009). Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann. Thorac. Surg. 88, 1036-1043.
2. Afzal, M.R., Haider, H., Idris, N.M., Jiang, S., Ahmed, R.P., and Ashraf, M. (2010). Preconditioning promotes survival and angiomyogenic potential of mesenchymal stem cells in the infarcted heart via NF-kB signaling. Antioxid. Redox Signal. 12, 693-702.
3. Airey, J.A., Almeida-Porada, G., Colletti, E.J., Porada, C.D., Chamberlain, J., Movsesian, M., Sutko, J.L., and Zanjani, E.D. (2004). Human mesenchymal stem cells form Purkinje fibers in fetal sheep heart. Circulation 109, 1401-1407. (Pubitemid 38387827)
4. Alfaro, M.P., Vincent, A., Saraswati, S., Thorne, C.A., Hong, C.C., Lee, E., and Young, P.P. (2010). sFRP2 suppression of BMP and WNT signaling mediates mesenchymal stem cell (MSC) self-renewal promoting engraftment and myocardial repair. J. Biol. Chem. 285, 35645-35653.
5. Al Kindi, A.H., Asenjo, J.F., Ge, Y., Chen, G.Y., Bhathena, J., Chiu, R.C., Prakash, S., and Shum-Tim, D. (2010). Micro-encapsulation to reduce mechanical loss of microspheres: Implications in myocardial cell therapy. Eur. J. Cardiothorac. Surg. (in press).
6. Amado, L.C., Saliaris, A.P., Schuleri, K.H., St John, M., Xie, J.S., Cattaneo, S., Durand, D.J., Fitton, T., Kuang, J.Q., Stewart, G., Lehrke, S., Baumgartner, W.W., Martin, B.J., Heldman, A.W., and Hare, J.M. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 102, 11474-11479. (Pubitemid 41153844)
7. Arminan, A., Gandia, C., Bartual, M., Garcia-Verdugo, J.M., Lledo, E., Mirabet, V., Llop, M., Barea, J., Montero, J.A., and Sepulveda, P. (2009). Cardiac differentiation is driven by NKX2.5 and GATA4 nuclear translocation in tissue-specific mesenchymal stem cells. Stem Cells Dev. 18, 907-918.
8. Assis, A.C., Carvalho, J.L., Jacoby, B.A., Ferreira, R.L., Castanheira, P., Diniz, S.O., Cardoso, V.N., Goes, A.M., and Ferreira, A.J. (2010). Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant. 19, 219-230.
9. Bao, C., Guo, J., Lin, G., Hu, M., and Hu, Z. (2008). TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI. Scand. Cardiovasc. J. 42, 56-62. (Pubitemid 351462231)
10. Bartosh, T.J., Ylostalo, J.H., Mohammadipoor, A., Bazhanov, N., Coble, K., Claypool, K., Lee, R.H., Choi, H., and Prockop, D.J. (2010). Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U.S.A. 107, 13724-13729.
11. Bayes-Genis, A., Soler-Botija, C., Farre, J., Sepulveda, P., Raya, A., Roura, S., Prat-Vidal, C., Galvez-Monton, C., Mon-tero, J.A., Buscher, D., and Belmonte, J.C. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J. Mol. Cell. Cardiol. 49, 771-780.
12. Behfar, A., Yamada, S., Crespo-Diaz, R., Nesbitt, J.J., Rowe, L.A., Perez-Terzic, C., Gaussin, V., Homsy, C., Bartunek, J., and Terzic, A. (2010). Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. 56, 721-734.
13. Belmadani, S., Matrougui, K., Kolz, C., Pung, Y.F., Palen, D., Prockop, D.J., and Chilian, W.M. (2009). Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor. Arterioscler. Thromb. Vasc. Biol. 29, 802-808.
14. Benzhi, C., Limei, Z., Ning, W., Jiaqi, L., Songling, Z., Fanyu, M., Hongyu, Z., Yanjie, L., Jing, A., and Baofeng, Y. (2009). Bone marrow mesenchymal stem cells upregulate transient outward potassium currents in postnatal rat ventricular myocytes. J. Mol. Cell. Cardiol. 47, 41-48.
15. 1-mediated cardiomyogenic marker expression in bone-marrow-derived mesenchymal stem cells in vitro. Biotechnol. Appl. Biochem. 55, 191-197.
16. Bieback, K., Kern, S., Kluter, H., and Eichler, H. (2004). Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22, 625-634. (Pubitemid 39014578)
17. Caplan, A.I. (1991). Mesenchymal stem cells. J. Orthop. Res. 9, 641-650.
18. Caplan, A.I. (2008). All MSCs are pericytes? Cell Stem Cell 3, 229-230.
19. Castillo, A.B., and Jacobs, C.R. (2010). Mesenchymal stem cell mechanobiology. Curr. Osteoporos. Rep. 8, 98-104.
20. Chacko, S.M., Ahmed, S., Selvendiran, K., Kuppusamy, M.L., Khan, M., and Kuppusamy, P. (2010). Hypoxic preconditioning induces the expression of pro-survival and pro-angiogenic markers in mesenchymal stem cells. Am. J. Physiol. Cell. Physiol. 299, C1562-C1570.
21. Chang, S.A., Lee, E.J., Kang, H.J., Zhang, S.Y., Kim, J.H., Li, L., Youn, S.W., Lee, C.S., Kim, K.H., Won, J.Y., Sohn, J.W., Park, K.W., Cho, H.J., Yang, S.E., Oh, W.I., Yang, Y.S., Ho, W.K., Park, Y.B., and Kim, H.S. (2008). Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: Effect of acute myocardial infarction on stem cell differentiation. Stem Cells 26, 1901-1912.
22. Chang, W., Song, B.W., Lim, S., Song, H., Shim, C.Y., Cha, M.J., Ahn, D.H., Jung, Y.G., Lee, D.H., Chung, J.H., Choi, K.D., Lee, S.K., Chung, N., Jang, Y., and Hwang, K.C. (2009). Mesen-chymal stem cells pretreated with delivered Hph-1-Hsp70 protein are protected from hypoxia-mediated cell death and rescue heart functions from myocardial injury. Stem Cells 27, 2283-2292.
23. Chen, M.Y., Lie, P.C., Li, Z.L., and Wei, X. (2009). Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 37, 629-640.
24. Chen, S., Liu, Z., Tian, N., Zhang, J., Yei, F., Duan, B., Zhu, Z., Lin, S., and Kwan, T.W. (2006). Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for is-chemic cardiomyopathy due to isolated chronic occluded left anterior descending artery. J. Invasive Cardiol. 18, 552-556. (Pubitemid 44704523)
25. Chen, S.L., Fang, W.W., Ye, F., Liu, Y.H., Qian, J., Shan, S.J., Zhang, J.J., Chunhua, R.Z., Liao, L.M., Lin, S., and Sun, J.P. (2004). Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92-95. (Pubitemid 38813459)
26. Cheng, A.S., and Yau, T.M. (2008). Paracrine effects of cell transplantation: Strategies to augment the efficacy of cell therapies. Semin. Thorac. Cardiovasc. Surg. 20, 94-101.
27. Cheng, F., Zou, P., Yang, H., Yu, Z., and Zhong, Z. (2003). Induced differentiation of human cord blood mesenchymal stem/progenitor cells into cardiomyocyte-like cells in vitro. J. Huazhong Univ. Sci. Technolog. Med. Sci. 23, 154-157. (Pubitemid 41559744)
28. Chin, S.P., Poey, A.C., Wong, C.Y., Chang, S.K., Teh, W., Mohr, T.J., and Cheong, S.K. (2010). Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. Cytotherapy 12, 31-37.
29. Crisan, M., Deasy, B., Gavina, M., Zheng, B., Huard, J., Lazzari, L., and Peault, B. (2008). Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: Myoendothelial cells and pericytes. Methods Cell Biol. 86, 295-309.
30. Cselenyak, A., Pankotai, E., Horvath, E.M., Kiss, L., and Lacza, Z. (2010). Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. 11, 29.
31. Dai, W., Hale, S.L., Kay, G.L., Jyrala, A.J., and Kloner, R.A. (2009). Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by na-noparticle technology. Regenerative Med. 4, 387-395.
32. da Silva Meirelles, L., Fontes, A.M., Covas, D.T., and Caplan, A.I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419-427.
33. Dixon, J.A., Gorman, R.C., Stroud, R.E., Bouges, S., Hirotsugu, H., Gorman, J.H., III, Martens, T.P., Itescu, S., Schuster, M.D., Plappert, T., St John-Sutton, M.G., and Spinale, F.G. (2009). Mesenchymal cell transplantation and myocardial remodeling after myocardial infarction. Circulation 120, S220-S229.
34. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317. (Pubitemid 44269669)
35. Dong, Q., Yang, Y., Song, L., Qian, H., and Xu, Z. (2010). Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating amp-activated protein kinase. Int. J. Cardiol. (in press).
36. Du, Y.Y., Zhou, S.H., Zhou, T., Su, H., Pan, H.W., Du, W.H., Liu, B., and Liu, Q.M. (2008). Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction. Cytotherapy 10, 469-478.
37. Duffy, G.P., Ahsan, T., O'Brien, T., Barry, F., and Nerem, R.M. (2009). Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng. Part A 15, 2459-2470.
38. Enoki, C., Otani, H., Sato, D., Okada, T., Hattori, R., and Imamura, H. (2010). Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction. Int. J. Cardiol. 138, 9-18.
39. Erwin, G.S., Crisostomo, P.R., Wang, Y., Wang, M., Markel, T.A., Guzman, M., Sando, I.C., Sharma, R., and Meldrum, D.R. (2009). Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. J. Surg. Res. 152, 319-324.
40. Fan, L., Lin, C., Zhuo, S., Chen, L., Liu, N., Luo, Y., Fang, J., Huang, Z., Lin, Y., and Chen, J. (2009). Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction. Eur. J. Heart Fail. 11, 1023-1030.
41. Fan, M., Chen, W., Liu, W., Du, G.Q., Jiang, S.L., Tian, W.C., Sun, L., Li, R.K., and Tian, H. (2010). The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res. 13, 429-438.
42. Feng, C., Zhu, J., Zhao, L., Lu, T., Zhang, W., Liu, Z., and Tian, J. (2009). Suberoylanilide hydroxamic acid promotes cardiomyocyte differentiation of rat mesenchymal stem cells. Exp. Cell Res. 315, 3044-3051.
43. Forte, G., Minieri, M., Cossa, P., Antenucci, D., Sala, M., Gnoc-chi, V., Fiaccavento, R., Carotenuto, F., De Vito, P., Baldini, P.M., Prat, M., and Di Nardo, P. (2006). Hepatocyte growth factor effects on mesenchymal stem cells: Proliferation, migration, and differentiation. Stem Cells 24, 23-33.
44. Furlani, D., Li, W., Pittermann, E., Klopsch, C., Wang, L., Knopp, A., Jungebluth, P., Thedinga, E., Havenstein, C., Westien, I., Ugurlucan, M., Li, R.K., Ma, N., and Steinhoff, G. (2009). A transformed cell population derived from cultured mesen-chymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant. 18, 319-331.
45. Galli, D., Innocenzi, A., Staszewsky, L., Zanetta, L., Sampaolesi, M., Bai, A., Martinoli, E., Carlo, E., Balconi, G., Fiordaliso, F., Chimenti, S., Cusella, G., Dejana, E., Cossu, G., and Latini, R. (2005). Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibro-blasts, and endothelial cells. Arterioscler. Thromb. Vasc. Biol. 25, 692-697. (Pubitemid 40463855)
46. Galvez, B.G., Sampaolesi, M., Barbuti, A., Crespi, A., Covarello, D., Brunelli, S., Dellavalle, A., Crippa, S., Balconi, G., Cuc-covillo, I., Molla, F., Staszewsky, L., Latini, R., Difrancesco, D., and Cossu, G. (2008). Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ. 15, 1417-1428.
47. Gao, L.R., Zhang, N.K., Bai, J., Ding, Q.A., Wang, Z.G., Zhu, Z.M., Fei, Y.X., Yang, Y., Xu, R.Y., and Chen, Y. (2010). The Apelin-APJ pathway exists in cardiomyogenic cells derived from mesenchymal stem cells in vitro and in vivo. Cell Transplant. 19, 949-958.
48. Garzoni, L.R., Rossi, M.I., De Barros, A.P., Guarani, V., Kera-midas, M., Balottin, L.B., Adesse, D., Takiya, C.M., Manso, P.P., Otazu, I.B., de Nazareth Meirelles, M., and Borojevic, R. (2009). Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells. Exp. Cell Res. 315, 3406-3418.
49. Ge, D., Liu, X., Li, L., Wu, J., Tu, Q., Shi, Y., and Chen, H. (2009). Chemical and physical stimuli induce cardiomyocyte differentiation from stem cells. Biochem. Biophys. Res. Commun. 381, 317-321.
50. Genovese, J.A., Spadaccio, C., Chachques, E., Schussler, O., Carpentier, A., Chachques, J.C., and Patel, A.N. (2009). Cardiac pre-differentiation of human mesenchymal stem cells by electrostimulation. Front. Biosci. 14, 2996-3002.
51. Ghanem, A., Steingen, C., Brenig, F., Funcke, F., Bai, Z.Y., Hall, C., Chin, C.T., Nickenig, G., Bloch, W., and Tiemann, K. (2009). Focused ultrasound-induced stimulation of micro-bubbles augments site-targeted engraftment of mesenchymal stem cells after acute myocardial infarction. J. Mol. Cell. Cardiol. 47, 411-418.
52. Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R.E., Ingwall, J.S., and Dzau, V.J. (2005). Paracrine action accounts for marked protection of is-chemic heart by Akt-modified mesenchymal stem cells. Nat. Med. 11, 367-368. (Pubitemid 40562318)
53. Grauss, R.W., Winter, E.M., Van Tuyn, J., Pijnappels, D.A., Steijn, R.V., Hogers, B., Van Der Geest, R.J., De Vries, A.A., Steendijk, P., Van Der Laarse, A., Gittenberger de Groot, A.C., Schalij, M.J., and Atsma, D.E. (2007). Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 293, H2438-H2447. (Pubitemid 47605891)
54. Grieve, S.M., Bhindi, R., Seow, J., Doyle, A., Turner, A.J., Tomka, J., Lay, W., Gill, A., Hunyor, S.N., and Figtree, G.A. (2010). Microvascular obstruction by intracoronary delivery of mes-enchymal stem cells and quantification of resulting myocardial infarction by cardiac magnetic resonance. Circ. Heart Fail. 3, e5-e6.
55. Grinnemo, K.H., Mansson, A., Dellgren, G., Klingberg, D., Wardell, E., Drvota, V., Tammik, C., Holgersson, J., Ringden, O., Sylven, C., and Le Blanc, K. (2004). Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. J. Thorac. Cardiovasc. Surg. 127, 1293-1300. (Pubitemid 38560590)
56. Haag, M., Van Linthout, S., Schroder, S.E., Freymann, U., Ringe, J., Tschope, C., and Sittinger, M. (2010). Endomyocardial biopsy derived adherent proliferating cells-a potential cell source for cardiac tissue engineering. J. Cell. Biochem. 109, 564-575.
57. Hacia, J.G., Lee, C.C., Jimenez, D.F., Karaman, M.W., Ho, V.V., Siegmund, K.D., and Tarantal, A.F. (2008). Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells. J. Cell. Biochem. 103, 1198-1210. (Pubitemid 351342609)
58. Haider, H.K., Lee, Y.J., Jiang, S., Ahmad, R.P., Ryon, M.D., and Ashraf, M. (2010). Phosphodiesterase inhibition with tadalafil provides longer and sustained protection of stem cells. Am. J. Physiol. Heart Circ. Physiol. 299, H1395-H1404.
59. Hakuno, D., Fukuda, K., Makino, S., Konishi, F., Tomita, Y., Manabe, T., Suzuki, Y., Umezawa, A., and Ogawa, S. (2002). Bone marrow-derived regenerated cardiomyocytes (CMG cells) express functional adrenergic and muscarinic receptors. Circulation 105, 380-386. (Pubitemid 34106189)
60. Hamamoto, H., Gorman, J.H., III, Ryan, L.P., Hinmon, R., Martens, T.P., Schuster, M.D., Plappert, T., Kiupel, M., St John-Sutton, M.G., Itescu, S., and Gorman, R.C. (2009). Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. Ann. Thorac. Surg. 87, 794-801.
61. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., Gerstenblith, G., Demaria, A.N., Denktas, A.E., Gammon, R.S., Hermiller, J.B., Jr., Reisman, M.A., Schaer, G.L., and Sherman, W.(2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286.
62. Hattan, N., Kawaguchi, H., Ando, K., Kuwabara, E., Fujita, J., Murata, M., Suematsu, M., Mori, H., and Fukuda, K. (2005). Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc. Res. 65, 334-344. (Pubitemid 40082475)
63. Hatzistergos, K.E., Quevedo, H., Oskouei, B.N., Hu, Q., Fei-genbaum, G.S., Margitich, I.S., Mazhari, R., Boyle, A.J., Zam-brano, J.P., Rodriguez, J.E., Dulce, R., Pattany, P.M., Valdes, D., Revilla, C., Heldman, A.W., McNiece, I., and Hare, J.M. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ. Res. 107, 913-922.
64. He, X.Q., Chen, M.S., Li, S.H., Liu, S.M., Zhong, Y., McDonald Kinkaid, H.Y., Lu, W.Y., Weisel, R.D., and Li, R.K. (2010). Co-culture with cardiomyocytes enhanced the myogenic conversion of mesenchymal stromal cells in a dose-dependent manner. Mol. Cell. Biochem. 339, 89-98.
65. Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., Martin, H., Zeiher, A.M., and Dimmeler, S. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109, 1615-1622. (Pubitemid 38451717)
66. Herrmann, J.L., Abarbanell, A.M., Weil, B.R., Wang, Y., Poynter, J.A., Manukyan, M.C., and Meldrum, D.R. (2010a). Postinfarct intramyocardial injection of mesenchymal stem cells pre-treated with TGF-a improves acute myocardial function. Am. J. Physiol. 299, R371-R378.
67. Herrmann, J.L., Wang, Y., Abarbanell, A.M., Weil, B.R., Tan, J., and Meldrum, D.R. (2010b). Preconditioning mesenchymal stem cells with transforming growth factor-a improves mesen-chymal stem cell-mediated cardioprotection. Shock 33, 24-30.
68. Hoogduijn, M.J., Crop, M.J., Peeters, A.M., Korevaar, S.S., Eij-ken, M., Drabbels, J.J., Roelen, D.L., Maat, A.P., Balk, A.H., Weimar, W., and Baan, C.C. (2009). Donorderived mesen-chymal stem cells remain present and functional in the transplanted human heart. Am. J. Transplant. 9, 222-230.
69. Hu, X., Yu, S.P., Fraser, J.L., Lu, Z., Ogle, M.E., Wang, J.A., and Wei, L. (2008). Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg. 135, 799-808. (Pubitemid 351417929)
70. Huang, J., Zhang, Z., Guo, J., Ni, A., Deb, A., Zhang, L., Mir-otsou, M., Pratt, R.E., and Dzau, V.J. (2010). Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium. Circ. Res. 106, 1753-1762.
71. Huang, N.F., Lam, A., Fang, Q., Sievers, R.E., Li, S., and Lee, R.J. (2009). Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium. Regenerative Med. 4, 527-538.
72. Ichim, T.E., Solano, F., Brenes, R., Glenn, E., Chang, J., Chan, K., and Riordan, N.H. (2008). Placental mesenchymal and cord blood stem cell therapy for dilated cardiomyopathy. Reprod. Biomed. Online 16, 898-905. (Pubitemid 351865356)
73. Ikegami, Y., Miyoshi, S., Nishiyama, N., Hida, N., Okamoto, K., Miyado, K., Segawa, K., Ogawa, S., and Umezawa, A. (2010). Serum-independent cardiomyogenic transdifferentiation in human endometrium-derived mesenchymal cells. Artif. Organs 34, 280-288.
74. Ishikane, S., Yamahara, K., Sada, M., Harada, K., Kodama, M., Ishibashi-Ueda, H., Hayakawa, K., Mishima, K., Iwasaki, K., Fujiwara, M., Kangawa, K., and Ikeda, T. (2010). Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. J. Mol. Cell. Cardiol. 49, 753-761.
75. Jiang, Y., Jahagirdar, B.N., Reinhardt, R.L., Schwartz, R.E., Keene, C.D., Ortiz-Gonzalez, X.R., Reyes, M., Lenvik, T., Lund, T., Blackstad, M., Du, J., Aldrich, S., Lisberg, A., Low, W.C., Largaespada, D.A., and Verfaillie, C.M. (2002). Plur-ipotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49. (Pubitemid 34742565)
76. Jin, B., Luo, X.P., Ni, H.C., Li, Y., and Shi, H.M. (2009). Cardiac matrix remodeling following intracoronary cell transplantation in dilated cardiomyopathic rabbits. Mol. Biol. Rep. 37, 3037-3042.
77. Jin, J., Jeong, S.I., Shin, Y.M., Lim, K.S., Shin, H., Lee, Y.M., Koh, H.C., and Kim, K.S. (2009). Transplantation of mesenchymal stem cells within a poly(lactide-co-e-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model. Eur. J. Heart Fail. 11, 147-153.
78. Jumabay, M., Zhang, R., Yao, Y., Goldhaber, J.I., and Bostrom, K.I. (2010). Spontaneously beating cardiomyocytes derived from white mature adipocytes. Cardiovasc. Res. 85, 17-27.
79. Kasper, G., Mao, L., Geissler, S., Draycheva, A., Trippens, J., Kuhnisch, J., Tschirschmann, M., Kaspar, K., Perka, C., Duda, G.N., and Klose, J. (2009). Insights into mesenchymal stem cell aging: Involvement of antioxidant defense and actin cyto-skeleton. Stem Cells 27, 1288-1297.
80. Katritsis, D.G., Sotiropoulou, P.A., Karvouni, E., Karabinos, I., Korovesis, S., Perez, S.A., Voridis, E.M., and Papamichail, M. (2005). Transcoronary transplantation of autologous mesen-chymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc. Interv. 65, 321-329. (Pubitemid 40898172)
81. Katritsis, D.G., Sotiropoulou, P., Giazitzoglou, E., Karvouni, E., and Papamichail, M. (2007). Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 9, 167-171. (Pubitemid 46404162)
82. Kelly, M.L., Wang, M., Crisostomo, P.R., Abarbanell, A.M., Herrmann, J.L., Weil, B.R., and Meldrum, D.R. (2010). Tnf receptor 2, not Tnf receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia. Shock 33, 602-607.
83. Khan, M., Meduru, S., Mohan, I.K., Kuppusamy, M.L., Wisel, S., Kulkarni, A., Rivera, B.K., Hamlin, R.L., and Kuppusamy, P. (2009a). Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J. Mol. Cell. Cardiol. 47, 275-287.
84. Khan, M., Mohsin, S., Khan, S.N., and Riazuddin, S. (2009b). Repair of senescent myocardium by mesenchymal stem cells is dependent on the age of donor mice. J. Cell Mol. Med. (in press).
85. Kim, B.O., Tian, H., Prasongsukarn, K., Wu, J., Angoulvant, D., Wnendt, S., Muhs, A., Spitkovsky, D., and Li, R.K. (2005). Cell transplantation improves ventricular function after a myo-cardial infarction: A preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation 112, I-96-I-104.
86. Kim, Y.S., Kwon, J.S., Hong, M.H., Kim, J., Song, C.H., Jeong, M.H., Cho, J.G., Park, J.C., Kang, J.C., and Ahn, Y. (2010). Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells. Artif. Organs 34, 453-461.
87. Kogler, G., Sensken, S., Airey, J.A., Trapp, T., Muschen, M., Feldhahn, N., Liedtke, S., Sorg, R.V., Fischer, J., Rosenbaum, C., Greschat, S., Knipper, A., Bender, J., Degistirici, O., Gao, J., Caplan, A.I., Colletti, E.J., Almeida-Porada, G., Muller, H.W., Zanjani, E., and Wernet, P. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200, 123-135. (Pubitemid 38982172)
88. Koninckx, R., Hensen, K., Daniels, A., Moreels, M., Lambrichts, I., Jongen, H., Clijsters, C., Mees, U., Steels, P., Hendrikx, M., and Rummens, J.L. (2009). Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy 11, 778-792.
89. Kraitchman, D.L., Heldman, A.W., Atalar, E., Amado, L.C., Martin, B.J., Pittenger, M.F., Hare, J.M., and Bulte, J.W. (2003). In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290-2293. (Pubitemid 36578497)
90. Labovsky, V., Hofer, E.L., Feldman, L., Fernandez Vallone, V., Garcia Rivello, H., Bayes-Genis, A., Hernando Insua, A., Levin, M.J., and Chasseing, N.A. (2010). Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes. Differentiation 79, 93-101.
91. Ladhoff, J., Fleischer, B., Hara, Y., Volk, H.D., and Seifert, M. (2010). Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc. Res. 88, 121-129.
92. Lai, R.C., Arslan, F., Lee, M.M., Sze, N.S., Choo, A., Chen, T.S., Salto-Tellez, M., Timmers, L., Lee, C.N., El Oakley, R.M., Pasterkamp, G., De Kleijn, D.P., and Lim, S.K. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4, 214-222.
93. Lai, V.K., Linares-Palomino, J., Nadal-Ginard, B., and Galinanes, M. (2009). Bone marrow cell-induced protection of the human myocardium: Characterization and mechanism of action. J. Thorac. Cardiovasc. Surg. 138, 1400-1408.e1401.
94. Lee, R.H., Pulin, A.A., Seo, M.J., Kota, D.J., Ylostalo, J., Larson, B.L., Semprun-Prieto, L., Delafontaine, P., and Prockop, D.J. (2009a). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5, 54-63.
95. 6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. Blood 113, 816-826.
96. Li, H., Yu, B., Zhang, Y., Pan, Z., Xu, W., and Li, H. (2006). Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem. Biophys. Res. Commun. 341, 320-325. (Pubitemid 43152109)
97. Li, H., Malhotra, D., Yeh, C.C., Tu, R., Zhu, B.Q., Birger, N., Wisneski, A., Cha, J., Karliner, J.S., and Mann, M.J. (2009). Myocardial survival signaling in response to stem cell transplantation. J. Am. Coll. Surg. 208, 607-613.
98. Li, J.H., Zhang, N., and Wang, J.A. (2008). Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J. Endocrinol. Invest. 31, 103-110. (Pubitemid 351596969)
99. Li, L., Zhang, Y., Li, Y., Yu, B., Xu, Y., Zhao, S., and Guan, Z. (2008). Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transpl. Int. 21, 1181-1189.
100. Li, L., Zhang, S., Zhang, Y., Yu, B., Xu, Y., and Guan, Z. (2009). Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure. Mol. Biol. Rep. 36, 725-731.
101. Li, W., Ma, N., Ong, L.L., Nesselmann, C., Klopsch, C., Ladilov, Y., Furlani, D., Piechaczek, C., Moebius, J.M., Lutzow, K., Lendlein, A., Stamm, C., Li, R.K., and Steinhoff, G. (2007). Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25, 2118-2127. (Pubitemid 47258191)
102. Li, Z., Guo, J., Chang, Q., and Zhang, A. (2009). Paracrine role for mesenchymal stem cells in acute myocardial infarction. Biol. Pharm. Bull. 32, 1343-1346.
103. Lin, Y.C., Leu, S., Sun, C.K., Yen, C.H., Kao, Y.H., Chang, L.T., Tsai, T.H., Chua, S., Fu, M., Ko, S.F., Wu, C.J., Lee, F.Y., and Yip, H.K. (2010). Early combined treatment with silde-nafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J. Transl. Med. 8, 88.
104. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. (1999). Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705. (Pubitemid 29122423)
105. Mangi, A.A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J.S., and Dzau, V.J. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 9, 1195-1201. (Pubitemid 37173705)
106. Markel, T.A., Crisostomo, P.R., Wang, M., Herring, C.M., and Meldrum, D.R. (2007). Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am. J. Physiol. 293, G657-G662. (Pubitemid 47605914)
107. Markel, T.A., Wang, Y., Herrmann, J.L., Crisostomo, P.R., Wang, M., Novotny, N.M., Herring, C.M., Tan, J., Lahm, T., and Meldrum, D.R. (2008). VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am. J. Physiol. Heart Circ. Physiol. 295, H2308-H2314.
108. Mastitskaya, S., and Denecke, B. (2009). Human spongiosa mesenchymal stem cells fail to generate cardiomyocytes in vitro. J. Negat. Results Biomed. 8, 11.
109. Mauney, J., Olsen, B.R., and Volloch, V. (2010). Matrix remodeling as stem cell recruitment event: A novel in vitro model for homing of human bone marrow stromal cells to the site of injury shows crucial role of extracellular collagen matrix. Matrix Biol. 29, 657-663.
110. Mazhari, R., and Hare, J.M. (2007). Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 4, S21-S26. (Pubitemid 46151902)
111. Menasche, P., Hagege, A.A., Scorsin, M., Pouzet, B., Desnos, M., Duboc, D., Schwartz, K., Vilquin, J.T., and Marolleau, J.P. (2001). Myoblast transplantation for heart failure. Lancet 357, 279-280. (Pubitemid 32120862)
112. Mias, C., Lairez, O., Trouche, E., Roncalli, J., Calise, D., Seguelas, M.H., Ordener, C., Piercecchi-Marti, M.D., Auge, N., Salvayre, A.N., Bourin, P., Parini, A., and Cussac, D. (2009). Mesen-chymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells 27, 2734-2743.
113. Min, J.J., Ahn, Y., Moon, S., Kim, Y.S., Park, J.E., Kim, S.M., Le, U.N., Wu, J.C., Joo, S.Y., Hong, M.H., Yang, D.H., Jeong, M.H., Song, C.H., Jeong, Y.H., Yoo, K.Y., Kang, K.S., and Bom, H.S. (2006). In vivo bioluminescence imaging of cord blood derived mesenchymal stem cell transplantation into rat myocardium. Ann. Nucl. Med. 20, 165-170. (Pubitemid 43925958)
114. Molina, E.J., Palma, J., Gupta, D., Torres, D., Gaughan, J.P., Houser, S., and Macha, M. (2008). Improvement in hemody-namic performance, exercise capacity, inflammatory profile, and left ventricular reverse remodeling after intracoronary delivery of mesenchymal stem cells in an experimental model of pressure overload hypertrophy. J. Thorac. Cardiovasc. Surg. 135, 292-299, 299.e291.
115. Molina, E.J., Palma, J., Gupta, D., Torres, D., Gaughan, J.P., Houser, S., and Macha, M. (2009). Reverse remodeling is associated with changes in extracellular matrix proteases and tissue inhibitors after mesenchymal stem cell (MSC) treatment of pressure overload hypertrophy. J. Tissue Eng. Regen. Med. 3, 85-91.
116. Nagaya, N., Kangawa, K., Itoh, T., Iwase, T., Murakami, S., Miyahara, Y., Fujii, T., Uematsu, M., Ohgushi, H., Yamagishi, M., Tokudome, T., Mori, H., Miyatake, K., and Kitamura, S. (2005). Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 112, 1128-1135. (Pubitemid 41216119)
117. Okada, M., Payne, T.R., Zheng, B., Oshima, H., Momoi, N., Tobita, K., Keller, B.B., Phillippi, J.A., Peault, B., and Huard, J. (2008). Myogenic endothelial cells purified from human skeletal muscle improve cardiac function after transplantation into infarcted myocardium. J. Am. Coll. Cardiol. 52, 1869-1880.
118. Okamoto, K., Miyoshi, S., Toyoda, M., Hida, N., Ikegami, Y., Makino, H., Nishiyama, N., Tsuji, H., Cui, C.H., Segawa, K., Uyama, T., Kami, D., Miyado, K., Asada, H., Matsumoto, K., Saito, H., Yoshimura, Y., Ogawa, S., Aeba, R., Yozu, R., and Umezawa, A. (2007). "Working" cardiomyocytes exhibiting plateau action potentials from human placenta-derived ex-traembryonic mesodermal cells. Exp. Cell Res. 313, 2550-2562. (Pubitemid 46977342)
119. Park, J.S., Huang, N.F., Kurpinski, K.T., Patel, S., Hsu, S., and Li, S. (2007). Mechanobiology of mesenchymal stem cells and their use in cardiovascular repair. Front. Biosci. 12, 5098-5116.
120. Peran, M., Marchal, J.A., Lopez, E., Jimenez-Navarro, M., Boulaiz, H., Rodriguez-Serrano, F., Carrillo, E., Sanchez-Espin, G., De Teresa, E., Tosh, D., and Aranega, A. (2010). Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy 12, 332-337.
121. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147. (Pubitemid 29282067)
122. Poncelet, A.J., Hiel, A.L., Vercruysse, J., Hermans, D., Zech, F., and Gianello, P. (2010). Intracardiac allogeneic mesenchymal stem cell transplantation elicits neo-angiogenesis in a fully immunocompetent ischaemic swine model. Eur. J. Cardi-othorac. Surg. 38, 781-787.
123. Prockop, D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74. (Pubitemid 27161245)
124. Psaltis, P.J., Paton, S., See, F., Arthur, A., Martin, S., Itescu, S., Worthley, S.G., Gronthos, S., and Zannettino, A.C. (2010). Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations. J. Cell. Physiol. 223, 530-540.
125. Quevedo, H.C., Hatzistergos, K.E., Oskouei, B.N., Feigenbaum, G.S., Rodriguez, J.E., Valdes, D., Pattany, P.M., Zambrano, J.P., HU, Q., McNiece, I., Heldman, A.W., and Hare, J.M. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. U.S.A. 106, 14022-14027.
126. Rebelatto, C.K., Aguiar, A.M., Senegaglia, A.C., Aita, C.M., Hansen, P., Barchiki, F., Kuligovski, C., Olandoski, M., Mou-tinho, J.A., Dallagiovanna, B., Goldenberg, S., Brofman, P.S., Nakao, L.S., and Correa, A. (2009). Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents. Biochem. Biophys. Res. Commun. 378, 456-461.
127. Renner, P., Eggenhofer, E., Rosenauer, A., Popp, F.C., Stein-mann, J.F., Slowik, P., Geissler, E.K., Piso, P., Schlitt, H.J., and Dahlke, M.H. (2009). Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosup-pressive function. Transplant. Proc. 41, 2607-2611.
128. Rogers, T.B., Pati, S., Gaa, S., Riley, D., Khakoo, A.Y., Patel, S., Wardlow, R.D., II, Frederick, C.A., Hall, G., He, L.P., and Lederer, W.J. (2010). Mesenchymal stem cells stimulate protective genetic reprogramming of injured cardiac ventricular myocytes. J. Mol. Cell. Cardiol. (in press).
129. \+ mesenchymal stem cells. Eur. J. Heart Fail. 8, 555-563. (Pubitemid 44604351)
130. Roura, S., Farre, J., Hove-Madsen, L., Prat-Vidal, C., Soler-Botija, C., Galvez-Monton, C., Vilalta, M., and Bayes-Genis, A. (2010). Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells. Basic Res. Cardiol. 105, 419-430.
131. Rubina, K., Kalinina, N., Efimenko, A., Lopatina, T., Melikhova, V., Tsokolaeva, Z., Sysoeva, V., Tkachuk, V., and Parfyonova, Y. (2009). Adipose stromal cells stimulate angiogenesis via promoting progenitor cell differentiation, secretion of angiogenic factors, and enhancing vessel maturation. Tissue Eng. Part A 15, 2039-2050.
132. Schaefer, A., Meyer, G.P., Fuchs, M., Klein, G., Kaplan, M., Wollert, K.C., and Drexler, H. (2006). Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: Results from the BOOST trial. Eur. Heart J. 27, 929-935.
133. Schneider, C., Jaquet, K., Geidel, S., Rau, T., Malisius, R., Boczor, S., Zienkiewicz, T., Kuck, K.H., and Krause, K. (2009). Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: Strain rate imaging in a model of hibernating myocardium. J. Am. Soc. Echocardiogr. 22, 1180-1189.
134. Schuleri, K.H., Feigenbaum, G.S., Centola, M., Weiss, E.S., Zimmet, J.M., Turney, J., Kellner, J., Zviman, M.M., Hatzis-tergos, K.E., Detrick, B., Conte, J.V., McNiece, I., Steenbergen, C., Lardo, A.C., and Hare, J.M. (2009). Autologous mesen-chymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur. Heart J. 30, 2722-2732.
135. Sethe, S., Scutt, A., and Stolzing, A. (2006). Aging of mesen-chymal stem cells. Ageing Res. Rev. 5, 91-116.
136. Shabbir, A., Zisa, D., Suzuki, G., and Lee, T. (2009). Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: A noninvasive therapeutic regimen. Am. J. Physiol. Heart Circ. Physiol. 296, H1888-H1897.
137. Shabbir, A., Zisa, D., Lin, H., Mastri, M., Roloff, G., Suzuki, G., and Lee, T. (2010). Activation of host tissue trophic factors through JAK/STAT3 signaling: A mechanism of mesenchy-mal stem cell-mediated cardiac repair. Am. J. Physiol. Heart Circ. Physiol. 299, H1428-H1438.
138. Shake, J.G., Gruber, P.J., Baumgartner, W.A., Senechal, G., Meyers, J., Redmond, J.M., Pittenger, M.F., and Martin, B.J. (2002). Mesenchymal stem cell implantation in a swine myo-cardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. 73, 1919-1925; discussion 1926.
139. Shim, W.S., Tan, G., Gu, Y., Qian, L., Li, S., Chung, Y.Y., Lim, S.Y., Sim, E., Chuah, S.C., and Wong, P. (2010). Dose-dependent systolic contribution of differentiated stem cells in post-infarct ventricular function. J. Heart Lung Transplant. 29, 1415-1426.
140. Shu, T., Zeng, B., Ren, X., and Li, Y. (2010). HO-1 modified mesenchymal stem cells modulate MMPs/TIMPs system and adverse remodeling in infarcted myocardium. Tissue Cell 42, 217-222.
141. Sittichokechaiwut, A., Edwards, J.H., Scutt, A.M., and Reilly, G.C. (2010). Short bouts of mechanical loading are as effective as dexamethasone at inducing matrix production by human bone marrow mesenchymal stem cell. Eur. Cell. Mater. 20, 45-57.
142. Song, S.W., Chang, W., Song, B.W., Song, H., Lim, S., Kim, H.J., Cha, M.J., Choi, E., Im, S.H., Chang, B.C., Chung, N., Jang, Y., and Hwang, K.C. (2009). Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 27, 1358-1365.
143. Stamm, C., Westphal, B., Kleine, H.D., Petzsch, M., Kittner, C., Klinge, H., Schumichen, C., Nienaber, C.A., Freund, M., and Steinhoff, G. (2003). Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46. (Pubitemid 36050962)
144. Stamm, C., Nasseri, B., Choi, Y.H., and Hetzer, R. (2009). Cell therapy for heart disease: Great expectations, as yet unmet. Heart Lung Circ. 18, 245-256.
145. Steingen, C., Brenig, F., Baumgartner, L., Schmidt, J., Schmidt, A., and Bloch, W. (2008). Characterization of key mechanisms in transmigration and invasion of mesenchymal stem cells. J. Mol. Cell. Cardiol. 44, 1072-1084.
146. Tamaki, T., Akatsuka, A., Ando, K., Nakamura, Y., Matsuzawa, H., Hotta, T., Roy, R.R., and Edgerton, V.R. (2002). Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell Biol. 157, 571-577. (Pubitemid 34839786)
147. Tan, G., Shim, W., Gu, Y., Qian, L., Chung, Y.Y., Lim, S.Y., Yong, P., Sim, E., and Wong, P. (2010). Differential effect of myo-cardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells. Differentiation 79, 260-271.
148. Tan, M.Y., Zhi, W., Wei, R.Q., Huang, Y.C., Zhou, K.P., Tan, B., Deng, L., Luo, J.C., Li, X.Q., Xie, H.Q., and Yang, Z.M. (2009). Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30, 3234-3240.
149. Tang, J., Wang, J., Guo, L., Kong, X., Yang, J., Zheng, F., Zhang, L., and Huang, Y. (2010). Mesenchymal stem cells modified with stromal cell-derived factor 1a improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol. Cells 29, 9-19.
150. Tay, C.Y., Yu, H., Pal, M., Leong, W.S., Tan, N.S., Ng, K.W., Leong, D.T., and Tan, L.P. (2010). Micropatterned matrix directs differentiation of human mesenchymal stem cells towards myocardial lineage. Exp. Cell Res. 316, 1159-1168.
151. Thangarajah, H., Vial, I.N., Chang, E., El-Ftesi, S., Januszyk, M., Chang, E.I., Paterno, J., Neofytou, E., Longaker, M.T., and Gurtner, G.C. (2009). IFATS collection: Adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem Cells 27, 266-274.
152. Tokalov, S.V., Gruener, S., Schindler, S., Iagunov, A.S., Bau-mann, M., and Abolmaali, N.D. (2007a). A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol. Cells 24, 255-260. (Pubitemid 350177186)
153. Tokalov, S.V., Gruner, S., Schindler, S., Wolf, G., Baumann, M., and Abolmaali, N. (2007b). Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev. 16, 439-446. (Pubitemid 47016229)
154. Toma, C., Pittenger, M.F., Cahill, K.S., Byrne, B.J., and Kessler, P.D. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98. (Pubitemid 34049148)
155. Tsuji, H., Miyoshi, S., Ikegami, Y., Hida, N., Asada, H., Togashi, I., Suzuki, J., Satake, M., Nakamizo, H., Tanaka, M., Mori, T., Segawa, K., Nishiyama, N., Inoue, J., Makino, H., Miyado, K., Ogawa, S., Yoshimura, Y., and Umezawa, A. (2010). Xeno-grafted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdiffer-entiated into cardiomyocytes. Circ. Res. 106, 1613-1623.
156. Ventura, C., Cantoni, S., Bianchi, F., Lionetti, V., Cavallini, C., Scarlata, I., Foroni, L., Maioli, M., Bonsi, L., Alviano, F., Fos-sati, V., Bagnara, G.P., Pasquinelli, G., Recchia, F.A., and Perbellini, A. (2007). Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J. Biol. Chem. 282, 14243-14252. (Pubitemid 47100449)
157. Wall, S.T., Yeh, C.C., Tu, R.Y., Mann, M.J., and Healy, K.E. (2010). Biomimetic matrices for myocardial stabilization and stem cell transplantation. J. Biomed. Mater. Res. A. 95, 1055-1066.
158. Wang, Y., Crisostomo, P.R., Wang, M., Markel, T.A., Novotny, N.M., and Meldrum, D.R. (2008). TGF-a increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K-but not JNK- or ERK-dependent mechanisms. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1115-R1123.
159. Weil, B.R., Manukyan, M.C., Herrmann, J.L., Wang, Y., Abar-banell, A.M., Poynter, J.A., and Meldrum, D.R. (2010). Mesenchymal stem cells attenuate myocardial functional depression and reduce systemic and myocardial inflammation during endotoxemia. Surgery 148, 444-452.
160. Yamada, Y., Yokoyama, S., Fukuda, N., Kidoya, H., Huang, X.Y., Naitoh, H., Satoh, N., and Takakura, N. (2007). A novel approach for myocardial regeneration with educated cord blood cells cocultured with cells from brown adipose tissue. Biochem. Biophys. Res. Commun. 353, 182-188. (Pubitemid 44958357)
161. Yang, M.C., Chi, N.H., Chou, N.K., Huang, Y.Y., Chung, T.W., Chang, Y.L., Liu, H.C., Shieh, M.J., and Wang, S.S. (2010a). The influence of rat mesenchymal stem cell CD44 surface markers on cell growth, fibronectin expression, and cardiomyogenic differentiation on silk fibroin-hyaluronic acid cardiac patches. Biomaterials 31, 854-862.
162. Yang, Z., Zhang, F., Ma, W., Chen, B., Zhou, F., Xu, Z., Zhang, Y., Zhang, D., Zhu, T., Wang, L., Wang, H., and Ding, Z. (2010b). A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: Delivery via a noninfarct-relative artery. Cardiovasc. Ther. 28, 380-385.
163. Yoon, Y.S., Wecker, A., Heyd, L., Park, J.S., Tkebuchava, T., Kusano, K., Hanley, A., Scadova, H., Qin, G., Cha, D.H., Johnson, K.L., Aikawa, R., Asahara, T., and Losordo, D.W. (2005). Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J. Clin. Invest. 115, 326-338. (Pubitemid 40385474)
164. Yu, J., Du, K.T., Fang, Q., Gu, Y., Mihardja, S.S., Sievers, R.E., Wu, J.C., and Lee, R.J. (2010). The use of human mesenchymal stem cells encapsulated in RGD modified alginate micro-spheres in the repair of myocardial infarction in the rat. Biomaterials 31, 7012-7020.
165. Zeinaloo, A., Zanjani, K.S., Bagheri, M.M., Mohyeddin-Bonab, M., Monajemzadeh, M., and Arjmandnia, M.H. (2010). In-tracoronary administration of autologous mesenchymal stem cells in a critically ill patient with dilated cardiomyopathy. Pediatr. Transplant. (in press).
166. Zhang, H., Fazel, S., Tian, H., Mickle, D.A., Weisel, R.D., Fujii, T., and Li, R.K. (2005). Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. Am. J. Physiol. Heart Circ. Physiol. 289, H2089-H2096. (Pubitemid 41507361)
167. Zheng, H., Martin, J.A., Duwayri, Y., Falcon, G., and Buckwal-ter, J.A. (2007). Impact of aging on rat bone marrow-derived stem cell chondrogenesis. J. Gerontol. 62, 136-148. (Pubitemid 47065737)